We are live on
!
Find out more
WI
Wafra Inc Portfolio holdings
AUM
$5.95M
1-Year Est. Return
6.19%
This Fund
S&P 500
This Quarter
Est. Return
-13.17%
1 Year Est. Return
-6.19%
3 Year Est. Return
-37.84%
5 Year Est. Return
-32.03%
10 Year Est. Return
+62.69%
AUM
$2.55B
AUM Growth
-$381M
(-13%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
71.1%
Holding
94
New
9
Increased
20
Reduced
11
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$29.1M |
| 2 |
Baker Hughes
BKR
|
+$18.1M |
| 3 |
CVS Health
CVS
|
+$13.8M |
| 4 |
Boston Scientific
BSX
|
+$12.2M |
| 5 |
Biogen
BIIB
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$25.3M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$21.5M |
| 3 |
Labcorp
LH
|
+$15.9M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$15.1M |
| 5 |
Humana
HUM
|
+$11.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.11% |
| 2 | Communication Services | 5.16% |
| 3 | Financials | 5.13% |
| 4 | Technology | 4.9% |
| 5 | Consumer Discretionary | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Stryker
SYK
$125B
| $314K | 0.01% |
2,004
| – | – |
|
|
SARA
77
DELISTED
SARATOGA RESOURCES INC
SARA
| $16K | ﹤0.01% |
780,483
| – | – |
|
|
DFS
78
DELISTED
Discover Financial Services
DFS
| – | – |
-198,078
| Closed | -$15.1M |
|
79
Devon Energy
DVN
$52.1B
| – | – |
-285,655
| Closed | -$11.4M |
|
|
80
Gilead Sciences
GILD
$162B
| – | – |
-328,125
| Closed | -$25.3M |
|
81
Halliburton
HAL
$26.9B
| – | – |
-12,335
| Closed | -$500K |
|
82
Lennar Class A
LEN
$19.8B
| – | – |
-243,261
| Closed | -$11M |
|
|
83
Labcorp
LH
$25.4B
| – | – |
-106,485
| Closed | -$15.9M |
|
84
Martin Marietta Materials
MLM
$31.5B
| – | – |
-47,800
| Closed | -$8.7M |
|
85
S&P Global
SPGI
$121B
| – | – |
-9,872
| Closed | -$1.93M |
|
|
VTLE
86
DELISTED
Vital Energy
VTLE
| – | – |
-24,722
| Closed | -$4.04M |
|
|
SOGO
87
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
| – | – |
-288,569
| Closed | -$2.14M |
|
|
WBC
88
DELISTED
WABCO HOLDINGS INC.
WBC
| – | – |
-59,731
| Closed | -$7.04M |
|
Similar funds
BM
PFGWM
SAS
GFM
AI
LA
OFC
RJA
Wafra Inc's Q4 2018 Portfolio in Review
As of Q4 2018, Wafra Inc held 94 positions worth $2.55B, down 13% from $2.93B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Wafra Inc's Q4 2018 filing shows 9 new, 20 increased, 11 reduced and 12 closed positions. Its largest new stake was CVS Health: 184,755 shares worth $12.1M. The largest sale was Gilead Sciences, an estimated $25.3M.
By sector, the portfolio is most concentrated in Healthcare at 6.1% of assets, down from 6.2% a quarter earlier, followed by Communication Services and Financials.
- Wafra Inc's largest Q4 2018 buy was CVS Health: 184,755 shares worth $12.1M.
- Wafra Inc added most to Vanguard FTSE Emerging Markets ETF in Q4 2018, an estimated $29.1M increase.
- Wafra Inc's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21.5M.
- Wafra Inc fully exited Gilead Sciences in Q4 2018, selling an estimated $25.3M.
- Wafra Inc's ten largest holdings make up 71% of its $2.55B portfolio in Q4 2018.
- Wafra Inc opened 9 new positions and closed 12 in Q4 2018.
- Wafra Inc's portfolio value fell 13% quarter-over-quarter to $2.55B.
Based on Wafra Inc's 13F filing for Q4 2018, filed 13 Feb 2019.